@ARTICLE{
author={Glimelius Bengt,Manojlovic Nebojsa S,Pfeiffer Per,Mosidze Baadur,Kurteva Galina,Karlberg Mia,Mahalingam Devalingam,Buhl Jensen Peter,Kowalski Jan,Bengtson Marie,Nittve Malin,Nasstrom Jacques},
year={2018},
title={Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx((R))): a placebo-controlled randomised phase II study (PLIANT)},
journal={ACTA ONCOLOGICA},
volume={57},
number={3},
pages={393-402},
document_type={Article},
} 

@ARTICLE{
author={Glimelius Bengt,Manojlovic Nebojsa S,Pfeiffer Per,Mosidze Baadur,Petrova-Kurteva Galina,Karlberg Mia,Mahalingam Devalingam,Bengtson Marie,Nasstrom Jacques},
year={2016},
title={Persistent prevention of CIPN using calmangafodipir (Pled Ox): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
}